Prioritising dermatology to reduce pressure on healthcare services Chronic skin conditions, particularly CHE, remain some of the most underestimated, yet pervasive, challenges affecting people across Europe.

#dermatology #BurdenofSkinDiseases #NHS #healthpolicy #ChronicHandEczema #CHE #psoriasis #atopicdermatitis #globalprevalencerate #Beyondtheskin #AllergyUK #LEOPharma #healthinequality #carepathways #dermatologyframework #NHS10YearHealthPlan #NHS10yearplan #medicaldermatologylandscape
zurl.co/htdYM

🎥 Exciting news! #WorldThrombosisDay has partnered with LEO Pharma to shine a spotlight on cancer-associated thrombosis (CAT).

This new series launching October 1 brings you expert insights on diagnosis, treatment and prevention ahead of #WTDay25 on October 13. Stay tuned!
#LEO #LeoPharma

It's time to Countdown to #WorldThrombosisDay 2025! For the next 13 days, with the help of our partners at Leo Pharma, we will be sharing important messages on cancer-associated thrombosis. To get us started, we want to hear one way that you will be recognizing #WTDay25
#LEOPharma

LEO bulks up with deal for Boehringer skin drug LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

#dermatology #LEO #Boehringer #LEOPharma #psoriasis #BoehringerIngelheim #Spevigo #spesolimab #IL36inhibitor #psoriasisflares #generalisedpustularpsoriasis #GPP #IL36mediatedskindiseases #palmoplantarpustulosis #hidradenitissuppurativa #congenitalichthyosis
pharmaphorum.com/news/leo-bul...

Danish dermatology specialist #LEOPharma has licensed a medicine for a rare form of #psoriasis from #BoehringerIngelheim, plugging a gap in its near-term product portfolio after a late-stage pipeline failure last year.

pharmaphorum.com/news/leo-bul...

Gilead and LEO Pharma partner to develop oral STAT6 program - PharmaTimes Companies aim to provide new treatments for inflammatory conditions

#GileadSciences #LEOPharma #strategicpartnership #drugdevelopment #atopicdermatitis #asthma #COPD #dermatology #skindiseases #respiratory #smallmoleculeinhibitors #targetedproteindegraders #STAT6pathway #oralSTAT6products #topicalSTAT6products
pharmatimes.com/uncategorize...

LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema LEO Pharma has secured marketing authorisation from the MHRA for its innovative treatment, Anzupgo® (delgocitinib) cream, marking a breakthrough for adults with moderate to severe Chronic Hand Eczema ...

www.linkedin.com/pulse/leo-ph...

LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema

#LEOPharma #ChronicHandEczema #AnzupgoCream #Delgocitinib #SkinHealth #NHSAccess #MedicalBreakthrough #HealthcareInnovation #Humanteconomy #Humantec

MHRA grants marketing authorisation for LEO Pharma’s eczema cream - Pf Media The MHRA has granted marketing authorisation for LEO Pharma’s cream for the treatment of patients with moderate to severe chronic hand eczema.

#dermatology #skindisease #MHRA #Anzupgo #delgocitinib #eczemacream #handeczema #chronichandeczema #LEOPharma #UKMHRA #topicalJAKinhibitor #JAKinhibitor #phase3clincialtrials #DELTA1clincialtrial #DELTA2clinicaltrial #DELTA3openlabelextensiontrial #NICE #NHS
pf-media.co.uk/news/mhra-gr...

LEO Pharma Ibéria com novo diretor-geral Juan Fran Cuello de Oro é o novo Diretor-Geral da LEO Pharma Ibéria, foi esta terça-feira anunciado.

Juan Fran Cuello de Oro é o novo Diretor-Geral da LEO Pharma Ibéria, foi esta terça-feira anunciado.
#healthnews #LeoPharma